Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 6653-96-9 | MDL No. : | MFCD10698052 |
Formula : | C6H6N4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DCLWNTIANRACSB-UHFFFAOYSA-N |
M.W : | 134.14 | Pubchem ID : | 10534704 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.39 |
TPSA : | 56.21 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.13 cm/s |
Log Po/w (iLOGP) : | 1.01 |
Log Po/w (XLOGP3) : | -0.02 |
Log Po/w (WLOGP) : | 0.32 |
Log Po/w (MLOGP) : | 0.39 |
Log Po/w (SILICOS-IT) : | -0.2 |
Consensus Log Po/w : | 0.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.33 |
Solubility : | 6.35 mg/ml ; 0.0473 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.71 |
Solubility : | 26.1 mg/ml ; 0.195 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.32 |
Solubility : | 6.41 mg/ml ; 0.0478 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.97 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 154704-35-5 ]
2-Methylimidazo[1,2-b]pyridazin-6-amine
Similarity: 0.89
[ 166176-46-1 ]
Imidazo[1,2-b]pyridazin-3-amine
Similarity: 0.82
[ 1260850-70-1 ]
3-Bromoimidazo[1,2-b]pyridazin-6-ylamine
Similarity: 0.82
[ 1161847-36-4 ]
6-Chloroimidazo[1,2-b]pyridazin-8-amine
Similarity: 0.73
[ 166176-45-0 ]
6-Chloroimidazo[1,2-b]pyridazin-3-amine
Similarity: 0.73
[ 154704-35-5 ]
2-Methylimidazo[1,2-b]pyridazin-6-amine
Similarity: 0.89
[ 1159977-65-7 ]
6-Bromoimidazo[1,2-b]pyridazine
Similarity: 0.85
[ 166176-46-1 ]
Imidazo[1,2-b]pyridazin-3-amine
Similarity: 0.82